Research & Development: Page 104
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Paper Chase The paperless clinical trial has yet to come to fruition. According to a recent Forrester Research survey of 400 CRAs and CRCs, 97% of current data-capture practices are still done via paper, 50% are through remote data entry, 35% are through scanning/fax, 25% are Web-enabled, 22%...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
November 2003 Contents 8 Keith Howells says the use of wireless devices at the point of care will increase. 32 For Jed Beitler, CRM — not DTC — is better suited for patient compliance. 44 Dr. Sidney Pestka is leading an interferon revolution. On the Cover The continuing evolution of EDC Electroni...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Cover
November 2003 The Forum for the Industry Executive Electronic Data Capture Coming of Age Pushing Science Forward with Sidney Pestka DTC’s Role in Improving Compliance Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on your mind opinions Preferred-provider status Increasingly, companies that provide services to the life-sciences industry are required to be on a preferred provider list. In the November issue of PharmaVOICE, we asked are innovative/new ideas being overlooked in some cases because a serv...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
December 2003 Contents 8 Cyndi Verst-Brasch says Phase IV trials have to withstand regulatory vigor. 20 Pharma is becoming more involved in choosing investigator sites, says Mark Eisenach. 32 For Dr. John Patton, the life sciences are awe inspiring. on the cover The value of Phase IV Postmarketin...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Art of Site Selection
By Denise Myshko The Art of Site Selection For pharmaceutical sponsors and their CRO partners, selecting the right investigator site is a linchpin to trial success. Quality sites have to have a well-trained staff, a patient-recruitment plan, experience in meeting or beating enrollment targets, lo...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
letter from the editor Phase IV studies can help differentiate a product from its competitors, medically support marketing objectives and messages, develop and enhance relationships with clinical investigators and key opinion leaders, increase physician exposure to a new drug, answer scientific q...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
December 2003 The forum for the industry executive PHASE IV TRIALS Balancing marketing and science adventuring forth with John Patton Marketing to nps and pas Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affecting the healthcare industry Profitable Biotech Companies Predicted to double in Next Few Years Therapeutic proteins and therapeutic antibodies collectively comprise almost 75% of biotech drugs currently on the market. Protein drugs also represent one of ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New electronic and web-based applications, sites, and technologies Solutions From PHT Provide Clinical Trial Savings and Flexibility Two recently launched offerings from PHT Corp., LogPad Phone and the Technology Transfer Program, aim to make the electronic capture of clinical-trial information e...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media New electronic and web-based applications, sites, and technologies Health Research International Launches Online Survey Capability Health Research International has launched its real-time, online survey capability. The online format complements the companyís existing survey expertise, enc...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Pharmacogenomics: The Next Step Forward
Pharmacogenomics The Next Step Forward The first NDA based on pharmacogenomic data may still be a long time coming, but in anticipation of such filings, the FDA has issued a draft guidance that encourages companies to conduct pharmacogenomic tests during the drug-development process. Pharmacogeno...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies The HBA – A National Brand The Healthcare Businesswomenís Association has undergone a reorganization and created a new Northeast Corridor Metro Chapter to better serve its members. The Healthcare Businesswomen’s Association (HBA)...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, marketing, And R&D Trends affecting the healthcare industry Parents Hesitant to let Children Participate in Clinical Trials Only one in four U.S. adults would consider allowing their children to participate in clinical trials. This is one of the results of a Harris Interact...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Developing a CDISC Intelligence Quotient
Developing a CDISC Intelligence Quotient Some CDISC members envision a time in the future when at least three of the CDISC standards will be combined into one. Until then, the question remains: what does CDISC-compliant mean to you? By breaking down the components of CDISC, people can better unde...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies Corbett Accel Healthcare Adds New Interactive Unit The new business unit, Kinect, fuses strategy with design and technology. Corbett Accel Healthcare Group has expanded its interactive offerings with the establishment of Kinect. ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media New Electronic and Web-based Applications, Sites, and Technologies Wolters Kluwer Launches Web Portal and Monitoring Service Wolters Kluwer Health Pharma Solutions business unit has launched the Website adisonline.info. The site is designed to inform clinicians and researchers about devel...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
January 10-11 Clarifying the Regulatory Framework of Pharmaceutical Marketing Philadelphia For more information, contact Anne Marie Coluccio, PTi international, at 212-661-3500 ext. 3229, e-mail [email protected], or visit pti-international.com. January 24-25 Manage the Cost of Spec...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter From the Editor
Letter From The Editor More than 40% of executives recently surveyed by Datamonitor believe their companies are failing to commit adequate time and resources to portfolio management and futhermore, 25% believe their organizations have little ability to implement and execute portfolio management e...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover Prioritizing the pipeline: The role of portfolio management Increased pressures on the pharmaceutical industry ó from shrinking pipelines to rising costs, reimbursement issues, and regulatory pressures ó mean companies have to find ways to focus on the projects that will meet corpora...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on your mind opinions Year in Review Continuing regulatory scrutiny, an economy yet to rebound, and evolving world events are some of the hallmarks for 2003. As 2004 approaches, PharmaVOICE asked how the trends and challenges of 2003 have impacted your business and how these market factors...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
January 2004 PharmaVOICE The forum for the industry executive portfolio management Strategies improving patient compliance with Dorothy Smith Device and Diagnostic Marketing www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies Market Measures/Cozint Forms Emerging Markets Team Group to focus exclusively on the market research needs of emerging pharma companies. Realizing that smaller and specialized companies involved in the healthcare field have unique requireme...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter From the Editor
Pharmaceutical manufacturers spent more in 2003 on new technology in most areas and less on maintaining existing technology than other manufacturing verticals, according to AMR Research. This is to be expected as many move to packaged or Web-based applications. Investments in databases, physical ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry New Drug Commercialization Costs Lead to Blockbuster Model’s End The high cost of commercialization is leading to the demise of the pharma industry’s blockbuster approach to developing new drugs, according to a stu...
By PharmaVoice Team • Jan. 2, 2008
Previous
